Wissenschaft
Publikationen
Wissenschaftliche Veröffentlichungen mit Beteiligung der Urologischen Universitätsklinik Heidelberg
Publikationserhebung des Jahres 2025
Publikationserhebung des Jahres 2024:
- Kaczorowski A, Chen X, Herpel E, Merseburger AS, Kristiansen G, Bernemann C, Hohenfellner M, Cronauer MV, Duensing S. Antibody selection influences the detection of AR-V7 in primary prostate cancer. Cancer Treat Res Commun. 2020;24:100186. doi: 10.1016/j.ctarc.2020.100186. Epub 2020 Jun 23. PMID: 32619831.
- Pfeffer T, Krug SM, Kracke T, Schürfeld R, Colbatzky F, Kirschner P, Medert R, Freichel M, Schumacher D, Bartosova M, Zarogiannis SG, Muckenthaler MU, Altamura S, Pezer S, Volk N, Schwab C, Duensing S, Fleming T, Heidenreich E, Zschocke J, Hell R, Poschet G, Schmitt CP, Peters V. Knock-out of dipeptidase CN2 in human proximal tubular cells disrupts dipeptide and amino acid homeostasis and para- and transcellular solute transport. Acta Physiol (Oxf). 2024 Apr;240(4):e14126. doi: 10.1111/apha.14126. Epub 2024 Mar 22. PMID: 38517248.
- Böning S, Schneider F, Huber AK, Langhoff D, Lin H, Kaczorowski A, Stenzinger A, Hohenfellner M, Duensing S, Duensing A. Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler. Immunooncol Technol. 2024 Aug 20;23:100727. doi: 10.1016/j.iotech.2024.100727. PMID: 39310847; PMCID: PMC11414714.
- Glemser PA, Freitag M, Kovacs B, Netzer N, Dimitrakopoulou-Strauss A, Haberkorn U, Maier-Hein K, Schwab C, Duensing S, Beuthien-Baumann B, Schlemmer HP, Bonekamp D, Giesel F, Sachpekidis C. Enhancing the diagnostic capacity of [18F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study. EJNMMI Rep. 2024 Nov 8;8(1):37. doi: 10.1186/s41824-024-00225-5. PMID: 39510993; PMCID: PMC11543981.
- Schütz V, Nessler CL, Duensing A, Zschäbitz S, Jäger D, Debus J, Hohenfellner M, Duensing S. Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatment. Front Oncol. 2024 Dec 10;14:1475914. doi: 10.3389/fonc.2024.1475914. PMID: 39720562; PMCID: PMC11666478.
- Weißer C, Netzer N, Görtz M, Schütz V, Hielscher T, Schwab C, Hohenfellner M, Schlemmer HP, Maier-Hein KH, Bonekamp D. Weakly Supervised MRI Slice-Level Deep Learning Classification of Prostate Cancer Approximates Full Voxel- and Slice-Level Annotation: Effect of Increasing Training Set Size. J Magn Reson Imaging. 2024 Apr;59(4):1409-1422. doi: 10.1002/jmri.28891. Epub 2023 Jul 28. PMID: 37504495.
- Baumgärtner K, Byczkowski M, Schmid T, Muschko M, Woessner P, Gerlach A, Bonekamp D, Schlemmer HP, Hohenfellner M, Görtz M. Effectiveness of the Medical Chatbot PROSCA to Inform Patients About Prostate Cancer: Results of a Randomized Controlled Trial. Eur Urol Open Sci. 2024 Sep 17;69:80-88. doi: 10.1016/j.euros.2024.08.022. PMID: 39329071; PMCID: PMC11424957.
- Huber AK, Kaczorowski A, Schneider F, Böning S, Görtz M, Langhoff D, Schwab C, Stenzinger A, Hohenfellner M, Duensing A, Duensing S. Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD. Sci Rep. 2024 Aug 31;14(1):20281. doi: 10.1038/s41598-024-71070-6. PMID: 39217197; PMCID: PMC11366015.
- Reimold P, Tosev G, Kaczorowski A, Friedhoff J, Schwab C, Schütz V, Görtz M, Panzer N, Heller M, Aksoy C, Himmelsbach R, Walle T, Zschäbitz S, Jäger D, Duensing A, Stenzinger A, Hohenfellner M, Duensing S. PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study. Diagnostics (Basel). 2024 Mar 30;14(7):741. doi: 10.3390/diagnostics14070741. PMID: 38611655; PMCID: PMC11011373.
- Kippenberger M, Schönberg G, Kaczorowski A, Schneider F, Böning S, Sun A, Schwab C, Görtz M, Schütz V, Stenzinger A, Hohenfellner M, Duensing A, Duensing S. Immune landscape of renal cell carcinoma with metastasis to the pancreas. Urol Oncol. 2024 Nov;42(11):373.e9-373.e17. doi: 10.1016/j.urolonc.2024.06.006. Epub 2024 Jul 8. PMID: 38981801.
- Lleshi E, Milne-Clark T, Lee Yu H, Martin HW, Hanson R, Lach R, Rossi SH, Riediger AL, Görtz M, Sültmann H, Flewitt A, Lynch AG, Gnanapragasam VJ, Massie CE, Dev HS. Prostate cancer detection through unbiased capture of methylated cell-free DNA. iScience. 2024 Jun 20;27(7):110330. doi: 10.1016/j.isci.2024.110330. PMID: 39055933; PMCID: PMC11269940.
- Schrader A, Netzer N, Hielscher T, Görtz M, Zhang KS, Schütz V, Stenzinger A, Hohenfellner M, Schlemmer HP, Bonekamp D. Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms. Eur Radiol. 2024 Dec;34(12):7909-7920. doi: 10.1007/s00330-024-10818-0. Epub 2024 Jul 2. PMID: 38955845; PMCID: PMC11557625.
- Janke F, Stritzke F, Dvornikovich K, Franke H, Angeles AK, Riediger AL, Ogrodnik S, Gerhardt S, Regnery S, Schröter P, Bauer L, Weusthof K, Görtz M, Harrabi S, Herfarth K, Neelsen C, Paech D, Schlemmer HP, Abdollahi A, Adeberg S, Debus J, Sültmann H, Held T. Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy. Int J Cancer. 2025 Feb 15;156(4):853-864. doi: 10.1002/ijc.35152. Epub 2024 Aug 30. PMID: 39212345; PMCID: PMC11661516.
- Sabagh M, Weber S, Sabetkish N, Ramouz A, Fakour S, Morath C, Mieth M, Zeier M, Khajeh E, Mehrabi A, Golriz M. Modified Peritoneal Fenestration as a Preventive Method for Lymphocele after Kidney Transplantation: A Preliminary Report. J Clin Med. 2024 Oct 2;13(19):5878. doi: 10.3390/jcm13195878. PMID: 39407938; PMCID: PMC11477912.
- Sabagh M, Sabetkish N, Fakour S, Ramouz A, Weber S, Mieth M, Lurje G, Golriz M, Zeier M, Mehrabi A, Khajeh E. Methods to prevent lymphocele after kidney transplantation: Seeking the optimal technique for avoiding a preventable complication. Transplant Rev (Orlando). 2024 Dec;38(4):100877. doi: 10.1016/j.trre.2024.100877. Epub 2024 Aug 7. PMID: 39142043.
- Weißer C, Netzer N, Görtz M, Schütz V, Hielscher T, Schwab C, Hohenfellner M, Schlemmer HP, Maier-Hein KH, Bonekamp D. Weakly Supervised MRI Slice-Level Deep Learning Classification of Prostate Cancer Approximates Full Voxel- and Slice-Level Annotation: Effect of Increasing Training Set Size. J Magn Reson Imaging. 2024 Apr;59(4):1409-1422. doi: 10.1002/jmri.28891. Epub 2023 Jul 28. PMID: 37504495.
- Stenzel PJ, Schindeldecker M, Seidmann L, Herpel E, Hohenfellner M, Hatiboglu G, Foersch S, Porubsky S, Macher-Goeppinger S, Roth W, Tagscherer KE. CD15 Is a Risk Predictor and a Novel Target in Clear Cell Renal Cell Carcinoma. Pathobiology. 2024;91(3):219-229. doi: 10.1159/000535201. Epub 2023 Nov 14. PMID: 37963432; PMCID: PMC11151972.